NYSE · CHE

Chemed Corporation

$509.34 -$1.79 (-0.35%) 1D After hours
Charting by TradingView

Key Metrics

$6.78B
Market cap
26.12×
P/E · TTM
$2.54B
Revenue · TTM
$259.78M
Net income
EPS · TTM $17.60
Dividend yield 0.5%
Free cash flow $377.12M
Beta · 1Y 0.09
EBITDA · TTM $414.64M
Gross margin —

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Apr 24
    The stock moved +10.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 24
  • Feb 26
    The stock moved -15.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 26

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$6.78B
Enterprise value$6.86B
Shares outstanding13.3M
52-wk range$365.21 – $517.74
Avg volume · 20D107.0K
Net cash −$74.34M
Book value / share$57.44
IndustryServices-Home Health Care Services
ExchangeNYSE
About Chemed Corporation
IPO dateJun 1, 1972
Employees15811

Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E26.12
P/S2.67
P/FCF17.99
EV/EBITDA16.54
EV/Sales2.70
Graham №$150.80

Profitability

Gross —
Operating 13.7%
Net 10.2%
FCF 14.8%
ROE / ROIC 30.6% · 28.2%

Financial Health

Current ratio0.85
Quick ratio0.83
Debt / equity0.11
Debt / EBITDA 0.22Low leverage
Net cash −$74.34M
Working capital−$47.35M

Cash Flow · TTM

Operating CF $443.75M
Capex −$66.63M
Free cash flow $377.12M
Buybacks $588.32M
Dividends paid $32.54M
Shareholder yield 9.2%

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

11.0
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$150.80 vs $509.34
Trades 3.4× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings